Search Results

Clomifene citrate 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Clomifene inhibits estrogen receptors in hypothalamus, inhibiting negative feedback of estrogen on gonadotropin release, leading to up-regulation of the hypothalamic-Cpituitary-Cadrenal axis.

More Information Supplier Page

Clomifene citrate 1000mg 1000mg  | Purity Not Available

Adooq Bioscience

Clomifene inhibits estrogen receptors in hypothalamus, inhibiting negative feedback of estrogen on gonadotropin release, leading to up-regulation of the hypothalamic-Cpituitary-Cadrenal axis.

More Information Supplier Page

Clofibrate 500mg 500mg  | Purity Not Available

Adooq Bioscience

Clofibrate increases the activity of extrahepatic lipoprotein lipase (LL), thereby increasing lipoprotein triglyceride lipolysis. Chylomicrons are degraded, VLDLs are converted to LDLs, and LDLs are converted to HDL.

More Information Supplier Page

Clofibrate 250mg 250mg  | Purity Not Available

Adooq Bioscience

Clofibrate increases the activity of extrahepatic lipoprotein lipase (LL), thereby increasing lipoprotein triglyceride lipolysis. Chylomicrons are degraded, VLDLs are converted to LDLs, and LDLs are converted to HDL.

More Information Supplier Page

Citalopram Hydrobromide 10mg 10mg  | Purity Not Available

Adooq Bioscience

Citalopram is a selective inhibitor of ST (5-hydroxytryptamine/serotonin transporter) and therefore is a potent and selective serotonin reuptake inhibitor.

More Information Supplier Page

Cisplatin 250mg 250mg  | Purity Not Available

Adooq Bioscience

Cisplatin was the first member of a class of platinum-containing anti-cancer drugs, which now also includes carboplatin and oxaliplatin. These platinum complexes react in vivo, binding to and causing crosslinking of DNA, which ultimately triggers apoptosis (programmed cell death).

More Information Supplier Page

Cisplatin 2g 2000mg  | Purity Not Available

Adooq Bioscience

Cisplatin was the first member of a class of platinum-containing anti-cancer drugs, which now also includes carboplatin and oxaliplatin. These platinum complexes react in vivo, binding to and causing crosslinking of DNA, which ultimately triggers apoptosis (programmed cell death).

More Information Supplier Page